Current through Register No. 40, October 3, 2024
(a) Each licensee
or registrant shall maintain records of doses received by all individuals for
whom monitoring was required pursuant to
He-P
4022.02, and records of doses received during planned
special exposures, accidents, and emergency conditions.
(b) Assessments of dose equivalent and
records made using units in effect before August 6, 1998, shall not have to be
changed.
(c) The records specified
in He-P
4021.07(a) shall include, when
applicable:
(1) The deep dose equivalent to
the whole body, lens dose equivalent, shallow dose equivalent to the skin, and
shallow dose equivalent to the extremities;
(2) The estimated intake of
radionuclides;
(3) The committed
effective dose equivalent assigned to the intake of radionuclides;
(4) The specific information used to
calculate the committed effective dose equivalent pursuant to
He-P
4020.08(a) and (c) , and when
required by He-P 4022.02;
(5) The total effective dose equivalent when
required by He-P 4020.06; and
(6) The total of the deep dose equivalent and
the committed dose to the organ receiving the highest total dose.
(d) The licensee or registrant
shall make entries of the records specified in
He-P
4021.07(a) at intervals not to
exceed one year.
(e) The licensee
or registrant shall maintain the records specified in
He-P
4021.07(a) on DHHS/RHS Form Z, or
equivalent containing the following:
(1) The
full name of the individual monitored for occupational radiation
dose;
(2) The monitored
individual's identification number and identification type;
(3) The sex of the monitored
individual;
(4) The date of birth
of the monitored individual in the format MM/DD/YYYY;
(5) The monitoring period for the which the
report is filed, in the format MM/DD/YYYY - MM/DD/YYYY;
(6) The name of the licensee or registrant;
(7) The license or registration
number or numbers;
(8) For the
monitoring period reported, an indication as to whether the dose data listed
represents:
a. A dose record, if the dose
data listed is a final determination of the dose received to the best of the
licensee's knowledge;
b. A dose
estimate, if the listed dose data are preliminary and will be superseded by a
final determination resulting in a subsequent report. An example of such an
instance shall be dose data based on self-reading dosimeter results and the
licensee intends to assign the record dose on the basis of TLD results that are
not yet available;
c. A routine
exposure, if the data represents the results of monitoring for routine
exposures; and
d. A planned special
exposure (PSE), if the data represents the results of monitoring of planned
special exposures. If more than one PSE was received in a single year, the
licensee or registrant shall sum them and report the total of all
PSEs;
(9) The symbol for
each radionuclide that resulted in an internal exposure recorded for the
individual;
(10) The lung
clearance class for all intakes by inhalation;
(11) The mode of intake, including
inhalation, absorption through the skin, oral ingestion, or
injection;
(12) The intake quantity
of each radionuclide in curies;
(13) For the monitoring period, the following
dose data:
a. The deep dose equivalent (DDE)
to the whole body;
b. The lens dose
equivalent (LDE) recorded for the lens of the eye;
c. The shallow dose equivalent recorded for
the skin of the whole body (SDE,WB);
d. The shallow dose equivalent recorded for
the skin of the extremity receiving the maximum dose (SDE, ME);
e. The committed effective dose equivalent
(CEDE) recorded for the maximally exposed organ, or "NR" for "Not Required" or
"NC" for "Not Calculated";
f. The
total effective dose equivalent (TEDE); and
g. The total organ dose equivalent (TODE) for
the maximally exposed organ;
(14) Additional comments, as necessary, to
demonstrate compliance with the dose limits. An example may be to enter the
note that the SDE,ME was the result of exposure from a discrete hot particle.
Another possibility shall be to indicate that an overexposed report has been
sent to the DHHS/RHS in reference to the exposure report; and
(15) The date and signature of the person
designated to represent the licensee or registrant, certifying that the
information contained on the form is complete and correct to the best of his or
her knowledge.
(f) The
licensee or registrant shall maintain the records of dose to an embryo/fetus
with the records of dose to the declared pregnant woman.
(g) The declaration of pregnancy, including
the estimated date of conception, shall also be kept on file, but may be
maintained separately from the dose records.
(h) The licensee or registrant shall retain
each required form or record until such time as each pertinent license or
registration requiring the record is terminated in accordance with this
chapter.
(i) The records required
under this section shall be protected from public disclosure, under the
authority of RSA
91-A:5, and the Privacy Act of 1974, Public
Law 93-579, 5 U.S.C.
552 a, because of their personal privacy
nature.
